发明名称 Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation
摘要 <p>The present invention relates to aromatic guanylhydrazone compounds of the formula &lt;CHEM&gt; wherein the characters in the formula have the following meanings: X1, X1', X1"   are - CR&lt;1&gt;=N-NH-C(NH)NH2; X2, X2', X2"   are -CR&lt;2&gt;=N-NH-C(NH)NH2, -H, -OCH3 Z is -H, -NH2, -CH=CH-COOH, -C6H5 (phenyl), -C5NH4 (pyridyl); -COOB, -OB, -OCOB, -C6H4-B, -C5NH3-B; -CR=N-NH-C(NH)NH2, ; -A-B; -A-C6H5, -A-OB, -A-(CHR)n-B, -A-(CHR)n- A'-B, -A-(CHR)n-Q-(CHR')m-B, -A-(CHR)n-Q-(CHR')m- A'-B A, A', A"   are -NHCO-, -CONH-, -NH;- R, R&lt;1&gt;, R&lt;2&gt;, R', R"   are -H, C1 - C3- alkyl; B is &lt;CHEM&gt; Q is &lt;CHEM&gt; n, m, o   are independently from each other integers from 0 to 10, and their use as pharmaceutically active agents as inhibitors of expression of CD83 molecules and maturation of dendritic cells. They are especially useful in organ transplantation.</p>
申请公布号 EP1389480(A1) 申请公布日期 2004.02.18
申请号 EP20020018317 申请日期 2002.08.14
申请人 MONDOBIOTECH INTERFERON SA 发明人 BEVEC, DORIAN
分类号 A61K31/165;A61K31/167;A61K31/17;A61K45/06;A61P37/00;A61P37/06;(IPC1-7):A61P37/06 主分类号 A61K31/165
代理机构 代理人
主权项
地址